Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer’s Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression

BACKGROUND: Cognitive reserve has been hypothesized as a mechanism to explain differences in individual risk for symptomatic expression of Alzheimer’s Disease (AD). Inappropriate medications may diminish cognitive reserve, precipitating the transition from preclinical AD (pAD) to a symptomatic state...

Descripción completa

Detalles Bibliográficos
Autores principales: Moga, Daniela C., Abner, E. L., Schmitt, F. A., Eckmann, L., Huffmyer, M., Martinez, A. I., Beech, B. F., George, R., El Khouli, R. H., Ali, D., Jicha, G. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145115/
https://www.ncbi.nlm.nih.gov/pubmed/36281668
http://dx.doi.org/10.14283/jpad.2022.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145115/
https://www.ncbi.nlm.nih.gov/pubmed/36281668
http://dx.doi.org/10.14283/jpad.2022.55

Ejemplares similares